mirtazapine has been researched along with Renal Insufficiency, Chronic in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although, compared to baseline, both gabapentin and mirtazapine treatment resulting in significant improvement in VAS scores, decreasing in pruritus severity was significantly greater in the mirtazapine treatment period compared with the gabapentin treatment period (P < 0." | 9.34 | Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study. ( Gholyaf, M; Mehrpooya, M; Mirjalili, M; Mohammadi, Y; Sheikh, V; Yasrebifar, F, 2020) |
| " Although, compared to baseline, both gabapentin and mirtazapine treatment resulting in significant improvement in VAS scores, decreasing in pruritus severity was significantly greater in the mirtazapine treatment period compared with the gabapentin treatment period (P < 0." | 5.34 | Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study. ( Gholyaf, M; Mehrpooya, M; Mirjalili, M; Mohammadi, Y; Sheikh, V; Yasrebifar, F, 2020) |
| "Cats with chronic kidney disease (CKD) often experience inappetence and vomiting and might benefit from the administration of mirtazapine, a medication with appetite stimulant and anti-nausea properties." | 5.17 | Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial. ( Lunn, KF; Quimby, JM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gholyaf, M | 1 |
| Sheikh, V | 1 |
| Yasrebifar, F | 1 |
| Mohammadi, Y | 1 |
| Mirjalili, M | 1 |
| Mehrpooya, M | 1 |
| Quimby, JM | 2 |
| Benson, KK | 1 |
| Summers, SC | 1 |
| Saffire, A | 1 |
| Herndon, AK | 1 |
| Bai, S | 1 |
| Gustafson, DL | 1 |
| Lunn, KF | 1 |
3 trials available for mirtazapine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study.
Topics: Adult; Aged; Aged, 80 and over; Cross-Over Studies; Female; Histamine H1 Antagonists; Humans; Male; | 2020 |
Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
Topics: Administration, Cutaneous; Animals; Appetite Stimulants; Cat Diseases; Cats; Double-Blind Method; Mi | 2020 |
Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
Topics: Animals; Anorexia; Antiemetics; Appetite Stimulants; Cat Diseases; Cats; Cross-Over Studies; Female; | 2013 |